Seattle Genetics reported $338.83M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Abbvie ABBV:US $ 9517M 1089M
Acadia Pharmaceuticals ACAD:US $ 112.52M 15.68M
Amgen AMGN:US $ 4677M 451M
Astellas Pharma 4503:JP Y 244955M 26313M
Bayer BAYN:GR 7.43B 1.54B
Biogen BIIB:US $ 1777.9M 295.8M
Biomarin Pharmaceutical BMRN:US $ 402.39M 72.33M
Bristol Myers Squibb BMY:US $ 9177M 452M
Clovis Oncology CLVS:US $ 24.83M 1.4M
Daiichi Sankyo 4568:JP Y 189062M 10573M
Eisai 4523:JP Y 158750M 35913M
Eli Lilly And LLY:US $ 5737.9M 211.8M
Esperion Therapeutics ESPR:US $ 11.71M 1.38M
Exelixis EXEL:US $ 342.78M 95.45M
Gilead Sciences GILD:US $ 5166M 549M
Glaxosmithkline GSK:US $ 6135M 283M
GlaxoSmithKline GSK:LN 6.14B 283M
Insmed INSM:US $ 40.92M 1.92M
Karyopharm Therapeutics KPTI:US $ 46.24M 79.28M
MacroGenics MGNX:US 11.05M 2.15M
Merk MRK:US $ 10567M 873M
Moderna Inc MRNA:US 5.05B 1.21B
Nektar Therapeutics NKTR:US $ 18.85M 0.76M
Novartis NOVN:VX 9.52B 3M
Pfizer PFE:US $ 15651M 1516M
Puma Biotechnology PBYI:US $ 34.89M 8.57M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
Seattle Genetics SGEN:US $ 338.83M 4.33M
Takeda 4502:JP Y 564909M 54981M
Teva Pharmaceutical TEVA:IT 2.12B 227M
Vertex Pharmaceuticals VRTX:US $ 1851.7M 26.53M
YTE INCY:US $ 696.02M 128.26M